Pharmaceuticals

This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.

News

August 10, 2009 โ€“ Health Care Service Corp. (HCSC), which operates the Blue Cross and Blue Shield plans in ...

Home August 10, 2009
Home
News

August 6, 2009 โ€“ Palatin Technologies Inc. said this week it received a notice of allowance from the U.S. Patent ...

Home August 06, 2009
Home
News

August 6, 2009 โ€“ Merck & Co. Schering-Plough Corp. and the companies' cholesterol joint venture, Merck/Schering ...

Home August 06, 2009
Home
News

August 5, 2009 โ€“ Nile Therapeutics Inc. said this week it dosed its first patient in a phase 2 clinical study of ...

Home August 05, 2009
Home
News

August 4, 2009 โ€“ Watson Pharmaceuticals Inc. said this week it received FDA approval on its abbreviated new drug ...

Home August 04, 2009
Home
Technology

August 3, 2009 โ€“ Kowa Research Institute (KRI) and Kowa Pharmaceuticals America Inc. (KPA) said today the FDA has ...

Home August 04, 2009
Home
Technology

July 31, 2009 โ€“ United Therapeutics Corp. said yesterday the FDA approved TYVASO (treprostinil) Inhalation ...

Home July 31, 2009
Home
News

July 28, 2009 โ€“ Sanofi-aventis said today MULTAQ (dronedarone) 400 mg tablets are now available in pharmacies in ...

Home July 28, 2009
Home
Technology

July 22, 2009 โ€“ The FDA this week approved Tekturna HCT (aliskiren and hydrochlorothiazide) tablets as initial ...

Home July 22, 2009
Home
Technology


July 13, 2009 โ€“ Daiichi Sankyo Inc. and Eli Lilly and Company said Friday the FDA approved Effient (prasugrel) ...

Home July 13, 2009
Home
News

July 10, 2009 โ€“ Merck & Co. Inc. and Portola Pharmaceuticals Inc. this week signed an exclusive global ...

Home July 10, 2009
Home
News

July 10, 2009 โ€“ New British Heart Foundation (BHF) research(1) revealed today suggests for the first time that ...

Home July 10, 2009
Home
Technology

July 6, 2009 โ€“ Sanofi-aventis said last week the FDA approved its Multaq (dronedarone) 400 mg tablets for use in ...

Home July 06, 2009
Home
News

July 1, 2009 โ€“ Cardioxyl Pharmaceuticals Inc. announced today the initiation of a phase I/IIa dose-escalation ...

Home July 01, 2009
Home
News

June 29, 2009 โ€“ Cordex Pharma said today it successfully completed the production of the ATPace clinical trial ...

Home June 29, 2009
Home
Subscribe Now